His scientific interests lie mostly in Pharmacology, Pharmacokinetics, Internal medicine, Adverse effect and Drug. His research in Pharmacology intersects with topics in Crossover study, Toxicity and Rifampicin. His Pharmacokinetics research incorporates themes from Hypericum, Warfarin and Dosing.
Andrew J. McLachlan usually deals with Internal medicine and limits it to topics linked to Anesthesia and Low back pain and Back pain. The study incorporates disciplines such as Physical therapy, Pharmacotherapy and Retrospective cohort study in addition to Adverse effect. He studied Confidence interval and Pediatrics that intersect with Polypharmacy.
His main research concerns Pharmacokinetics, Pharmacology, Internal medicine, Pharmacy and Family medicine. His study looks at the relationship between Pharmacokinetics and fields such as Chromatography, as well as how they intersect with chemical problems. Adverse effect and Confidence interval are the primary areas of interest in his Internal medicine study.
Andrew J. McLachlan has included themes like Placebo and Intensive care medicine in his Adverse effect study. In Placebo, he works on issues like Clinical trial, which are connected to Physical therapy and Randomized controlled trial. In his research, Psychological intervention is intimately related to MEDLINE, which falls under the overarching field of Family medicine.
Andrew J. McLachlan mostly deals with Internal medicine, Pharmacy, MEDLINE, Physical therapy and Health care. His Internal medicine study combines topics from a wide range of disciplines, such as Chronic pain and Oncology. His study in MEDLINE is interdisciplinary in nature, drawing from both Medical prescription, Pharmacotherapy and Dosing.
His research integrates issues of Acute low back pain, Low back pain, Quality of life, Intervention and Placebo in his study of Physical therapy. His work in Global health covers topics such as Mortality rate which are related to areas like Pharmacology. His study of Bioavailability is a part of Pharmacology.
Pharmacy, Health care, Polypharmacy, Pharmacist and MEDLINE are his primary areas of study. Andrew J. McLachlan interconnects Psychiatry, Older population, Older people and Ambivalence in the investigation of issues within Polypharmacy. His MEDLINE research integrates issues from Deprescriptions, Gerontology, Openness to experience, Pharmacotherapy and Medical prescription.
His Medical prescription research is classified as research in Pharmacology. The Pharmacology study which covers CYP3A that intersects with Drug. His Intensive care medicine study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Danijela Gnjidic;Sarah N. Hilmer;Sarah N. Hilmer;Fiona M. Blyth;Fiona M. Blyth;Vasi Naganathan;Vasi Naganathan.
Journal of Clinical Epidemiology (2012)
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.
Gustavo C. Machado;Chris G. Maher;Paulo H. Ferreira;Marina B. Pinheiro.
BMJ (2015)
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
Neal M. Davies;Andrew J. McLachlan;Ric O. Day;Kenneth M. Williams.
Clinical Pharmacokinectics (2000)
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
Nicole Lowres;Lis Neubeck;Glenn Salkeld;Ines Krass.
Thrombosis and Haemostasis (2014)
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Xuemin Jiang;Kenneth M. Williams;Winston S. Liauw;Alaina J. Ammit.
British Journal of Clinical Pharmacology (2004)
Medication withdrawal trials in people aged 65 years and older: a systematic review.
Shoba Iyer;Vasi Naganathan;Andrew J McLachlan;David G Le Couteur.
Drugs & Aging (2008)
Clinical pharmacology in the geriatric patient.
Sarah N. Hilmer;Andrew J. McLachlan;David G. Le Couteur.
Fundamental & Clinical Pharmacology (2007)
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
Alemayehu B Mekonnen;Andrew J McLachlan;Jo-anne E Brien.
BMJ Open (2016)
Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis.
Rafael Zambelli Pinto;Chris G. Maher;Manuela L. Ferreira;Mark Hancock.
Annals of Internal Medicine (2012)
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial.
Christopher M Williams;Christopher M Williams;Christopher G Maher;Jane Latimer;Andrew J McLachlan.
The Lancet (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Sydney
University of New South Wales
Royal North Shore Hospital
University of Sydney
Royal North Shore Hospital
University of Sydney
Erasmus University Rotterdam
University of Oxford
University of Manchester
University of Sydney
KU Leuven
University of Technology Sydney
The University of Texas at Austin
TU Bergakademie Freiberg
National Institute of Standards and Technology
University of California, Berkeley
National Institute of Advanced Industrial Science and Technology
Keio University
Yale University
University of Coimbra
Pennsylvania State University
Emory University
University of Iowa
University of Jyväskylä
Hong Kong Polytechnic University
University of California, Los Angeles